Summary by Moomoo AI
Trifoliage Biopharmaceuticals Limited (Trifoliage Biopharma-B) resubmitted the monthly report of securities changes as of September 30, 2024 to the Hong Kong Exchanges and Clearing Limited on November 6, 2024. The report indicates that the company's statutory/registered capital remains unchanged at 2,000,000,000 shares of common stock with a par value of $0.0001 per share, totaling $200,000. The issued shares (excluding treasury shares) increased from 1,297,048,929 shares in the previous month to 1,297,054,929 shares, an increase of 6,000 shares. This increase stems from the exercise of share options under the share options program prior to the initial public offering. The company confirms that all securities issuance, treasury share sales, or transfers have been formally authorized and approved by the board of directors and comply with all applicable listing rules, laws, and other regulatory requirements.
